n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, August 14th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Zynex, Inc. (ZYXI)

SmarTrend Newsletters, FeedBlitz, BUYINS.NET, TaglichBrothers, Zacks, FNNO Newsletters, Daily Markets, and SmallCapVoice reported earlier on Zynex, Inc. (ZYXI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company listed on the OTC Markets Group’s OTCQB. The Company specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. Furthermore, Zynex is developing a new blood volume monitor for use in hospitals and surgery centers.  Established in 1996, Zynex is based in Lone Tree, Colorado.

The Company markets and sells its own design of electrotherapy medical devices utilized for pain management and rehabilitation. In addition, Zynex markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.  Its product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold globally.  Zynex engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries.

Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets.

Zynex announced in March of 2015 that it submitted a Pre-Submission application to the FDA for its non-invasive Blood Volume Monitor, CM-1500. Zynex’s belief is that this will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.

The Company announced in September of 2015 that its wholly-owned subsidiary, Zynex Monitoring Solutions, filed an application with the FDA pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM-1500 monitoring device.

This past June, Zynex announced the appointment of Mr. Dan Moorhead as its Chief Financial Officer (CFO). Mr. Moorhead has more than two decades of experience in an array of finance roles serving private and public companies. He is a CPA (Certified Public Accountant) and holds a B.B.A. in Accounting from the University of Northern Colorado.

Also in June, Zynex announced that ColoradoBiz Magazine recognized the Company in Top100 Public Companies in its May/June 2017 issue. Zynex was ranked 90th on 2016 revenue of $13.3 million. This is up from 93rd in 2015 on $11.6 million in revenue. The Company earlier announced estimated Q2 2017 revenue of $3.8 million and EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of $650,000.

Zynex, Inc. (ZYXI), closed Monday's trading session at $1.10, up 35.80%, on 364,758 volume with 268 trades. The average volume for the last 60 days is 25,753 and the stock's 52-week low/high is $0.102/$0.91.

eWellness Healthcare Corp. (EWLL)

Penny Stock Prodigy and StockHideout reported earlier on eWellness Healthcare Corp. (EWLL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Culver City, California-based eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients via contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments. eWellness Healthcare lists on the OTC Markets Group’s OTCQB.

The Company’s business model is to license its PHZIO platform to any physical therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online.

The chief features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization.

Moreover, PHZIO scales a practice’s billable rates. It also provides tools to make growing a business easier. Pertaining to the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it’s a total on-line PT telemedicine intervention system.

eWellness Healthcare has launched a PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.

eWellness Healthcare anticipates adding Artificial Intelligence (AI) tools and predictive analytics into its PHZIO platform by the end of this year. The anticipation is that the new AI and predictive analytics will combine the Company’s existing remote monitoring capabilities with machine learning and intelligent analytics, which take advantage of patient health data to improve healthcare outcomes.

Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.

Last week, eWellness Healthcare and Total Release Physical Therapy announced an Integration & Marketing Agreement. Total Motion Release Seminars (TMR) is a proprietary physical therapy methodology developed by Mr. Tom Dalonzo-Baker, MPT. TMR is a full-body oriented assessment and treatment approach. TMR helps patients lessen their pain and impairments which limit their function. The treatment approach is created to allow physical therapists to interact and treat their patients remotely. The expectation is that integration with PHZIO will be extensively adopted within the TMR community.

eWellness Healthcare Corp. (EWLL), closed Monday's trading session at $0.1255, up 16.53%, on 121,443 volume with 24 trades. The average volume for the last 60 days is 616,015 and the stock's 52-week low/high is $0.0057/$0.54.

TSS, Inc. (TSSI)

RedChip, Marketbeat, and Wall Street Resources reported on TSS, Inc. (TSSI), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, TSS, Inc. is a data center and mission critical facilities and technology services enterprise. The Company is a single source provider of mission-critical planning, design, system integration, deployment, maintenance, and development of data centers facilities and information infrastructure. TSS is an innovator in the hyper-dynamic mission-critical facilities industry. The Company is based in Round Rock, Texas.

TSS is an innovator and leader in mission-critical infrastructure design and support services. These include Modular Data Centers, Assessments & Audits, Design & Budgeting, Project & Construction Services, Operations & Maintenance, and Planning & Analysis or Transformation Services. Its Data Center Services include Modular Data Centers; Data Center Health Check; Facility Assessment; Owners Representation; Strategic Options Analysis; CFD Assessment; Data Center Transition Planning; Information Technology (IT) Equipment Relocation Services; and Arc Flash-Hazard Analysis.

TSS has worked across numerous industries. The Company has planned, designed, built, as well as maintained specialized facilities. These include data centers, communications rooms, SCIFs, call centers, laboratories, trading floors, network operations centers, and medical facilities.

The Company provides a single-source solution for mission-critical facilities. It specializes in customizable end-to-end solutions powered by industry experts and creative services. These include technology consulting, engineering, design, project management, operations, facilities management, technology system installation and integration, and maintenance for traditional and modular data centers.

TSS integrates a facility’s electrical, mechanical, security, and building envelope into a unified strategic asset. The Company’s goal is to provide its customers with the most advanced and reliable mission-enabling solutions. Its expertise is in IT and integrated facilities services. The Company provides end-to-end solutions for all facets of a client’s critical facility projects.

An example of TSS’s solutions is the above-mentioned Modular Data Centers (MDCs). The Company provides MDC solutions, which help customers’ to cost-effectively design and deploy a data center founded on quality, scalability, maintainability, and portability. TSS can provide a customer with design, engineering, installation, and maintenance services to configure and support solutions unique to their requirements.

Concerning MDC Pre-Deployment, the Company offers Site Assessment, Site Design, and IT Integration. Regarding Deployment, it offers Site Preparation; Receiving; Rigging; Assembly/Connections; and Commissioning. Concerning Post-Deployment, it offers Warranty and Preventative Maintenance & Break/Fix Services

Today, (Monday, August 14, 2017) TSS reports its financial results for Q2 of 2017.

TSS, Inc. (TSSI), closed Monday's trading session at $0.1799, up 5.82%, on 13,500 volume with 6 trades. The average volume for the last 60 days is 17,710 and the stock's 52-week low/high is $0.04/$0.40.

Eco Tek 360, Inc. (ECTX)

InvestorsHub, MarketWatch, and TradingView reported on Eco Tek 360, Inc. (ECTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Eco Tek 360, Inc. provides contemporary, sustainably sourced casual clothing. The Company’s patented green technology allows it to provide sustainable uniforms. The Company formerly went by the name Global Fashion Technologies, Inc. It changed its corporate name to EcoTek360, Inc. in January 2017. Established in 2004, Eco Tek 360 is based in Somerville, New Jersey.

The Company concentrates on providing branded fabrics, apparel, and uniforms to the corporate, hotel, hospital, as well as military markets. Eco Tek 360’s state-of-the-art green technology permits it to collect and rejuvenate a customer’s used uniforms into new uniforms. Eco Tek 360 rejuvenates old uniforms and recovers the fiber to spin yarn, make fabric, and cut and sew new uniforms in its U.S. based facility.

The Company’s quality process is integrated from the collection of customers’ old uniforms by way of delivery to them from its New Jersey warehouse. Its in-house capabilities ensure versatility, world-class design, and responsiveness to support small batch construction for specialty products, unique sizing, and personalization with speedy turn times.

Eco Tek 360’s program for its customers is a four-step process – Recovery; Rejuvenation; Creation; and Shipping. Regarding Recovery, a customer collects/recovers their old uniforms and sends them to the Company. Through controlling their used uniforms, a customer improves their security. They receive a credit, which is good toward their subsequent uniform purchase.

Concerning Rejuvenation, Eco Tek 360’s patented process purifies old fiber into new, sustainably-sourced uniforms. This rejuvenated fiber is soft and strong. In addition, it saves 6,200 liters per cotton shirt.

Pertaining to Creation, the Company cuts and sews new uniforms from the rejuvenated fiber. Concerning Shipping, a customer’s new uniforms are ready for purchasing in Eco Tek 360’s secure online store. They are shipped directly to the customer.

Eco Tek 360 announced in February of this year that Mr. Paul Serbiak immediately assumed the role of Chief Executive Officer (CEO) at Eco Tek 360. Mr. Serbiak is a highly-qualified manager. He is the inventor of greater than 30 patented products and technologies.

Mr. Serbiak is also a Chemical Engineer and a highly-experienced manager. He held leadership positions at Procter & Gamble, Kimberly Clark, and Johnson & Johnson. His career includes serving as a Global Vice President at Johnson and Johnson and also senior strategic roles at Procter & Gamble and Kimberly Clark.

Eco Tek 360, Inc. (ECTX), closed Monday's trading session at $0.20, down 13.04%, on 8,300 volume with 3 trades. The average volume for the last 60 days is 14,982 and the stock's 52-week low/high is $0.05/$0.56.

FISION Corp. (FSSN)

MarketWatch, TradingView, and Bloomberg reported on FISION Corp. (FSSN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FISION Corp. is a cloud-based digital asset management and marketing automation company headquartered in Minneapolis, Minnesota. The Company serves enterprise clients in the health care, hospitality, financial/insurance, software, and technology industries. FISION has more than 65,000 users in 21 countries. Established in 2011, FISION lists on the OTC Markets Group’s OTCQB.

FISION is an effective sales enablement and marketing asset management tool. It maximizes the brand potential of every sales interaction. The Company’s advanced, proprietary technology specializes in managing customers’ brand and marketing content. This enables marketing and sales people to quickly and easily create compelling, personalized, on-brand communications, which increases revenue and profits.

FISION’s solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. The Company equips marketing and sales teams with a comprehensive set of enablement capabilities built to solve distributed marketing challenges. Concerning digital asset management, FISION’s centralized, cloud-based library supports close to 200 different file kinds and gives a client total control over how company assets are stored, retrieved, and used.

FISION has completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-based) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology.

Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, and sales enablement software. Volerro’s SaaS (Software as a Service) platform simplifies how enterprise teams create, refine, and distribute content.

Recently, FISION was awarded a U.S. patent (US9639551 B2) covering its cloud-based marketing technology called, “Computerized Sharing of Digital Asset Localization Between Organizations.”

FISION Chief Executive Officer, Mr. Mike Brown, said, “Our patented platform’s unique multi-tiered and multi-tenant functionality permits outside agencies and other marketing partners to securely access a company’s content repository, and create collateral materials that stays true to approved branding and messaging. It also provides administrators real-time visibility into the effectiveness of marketing and sales communication, measuring performance down to the individual asset and user level.”

FISION Corp. (FSSN), closed Monday's trading session at $0.15, down 21.05%, on 121,443 volume with 24 trades. The average volume for the last 60 days is 616,015 and the stock's 52-week low/high is $0.0057/$0.54.

graphic

The QualityStocks
Company Corner

graphic
graphic

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.6784, up 0.31%, on 63,253 volume with 60 trades. The stock’s average daily volume over the past 60 days is 43,162 and its 52-week low/high is $0.6171/$0.90.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global News:

ABcann Goes from RTO to $43 Million in Cash in 3 Months -- CFN Media

ABcann and Cannabis Wheaton Announce Closing of $15 Million Investment

ABcann Global Provides Construction and Expansion Update

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.92, up 5.75%, on 238,219 volume with 187 trades. The stock’s average daily volume over the past 60 days is 48,664 and its 52-week low/high is $0.30/$2.75.

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces the launch of its cryptocurrency education and trading subscription service on Chinesefn.com, the Company's dynamic financial website that provides real-time market commentary, analysis, and educational related services to Chinese-speaking investors. The new subscription service will cover timely news and will provide analysis regarding all aspects of the emerging digital currency world, including coverage of cryptocurrencies including bitcoin and ethereum, industry trends, price movement, sector related stocks and ETFs, etc.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com, Inc. Announces the Launch of its Cryptocurrency Education and Trading Subscription Service on Chinesefn.com

ChineseInvestors.com, Inc. Appoints Keevin Gillespie as the President of its Wholly-owned Subsidiary, ChineseHempOil.com, Inc.

NetworkNewsWire Announces Publication on the Influence of a New Budget Bill Amendment on the Medical Marijuana Sector

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.024, off by 19.19%, on 2,635,485 volume with 149 trades. The stock’s average daily volume over the past 60 days is 266,707, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (OTC PINK: GOHE) (the "Company") today announces that it has finalized and fully executed a Licensing Agreement with Cagney Global Logistics for the exclusive white labeling and implementation of the Global Reserve Platform. The Platform will be integrated into Cagney's existing delivery and payment component, the Final Mile solution, to enhance its Fortune 500 customer web sales. The finalization of this agreement comes on the heels of the Letter of Intent that was executed between the companies on May 1, 2017. Under the LOI, Global Payout and Cagney entered into advanced phases of planning the integration of the Global Reserve Platform into the existing processes and software currently utilized by Cagney for its logistics supply chain.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. Finalizes Licensing Agreement with Cagney Global Logistics for the use of the Global Payout Technology Platform

Global Payout, Inc. and MoneyTrac Technology Enter the Multi-Billion Dollar CBD Market through their Agreement with H Smart, Inc.

Marijuana Company of America Completes $250,000 Investment in MoneyTrac Technology

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0981, up 52.33%, on 117,107,887 volume with 6,085 trades. The stock’s average daily volume over the past 60 days is 14,464,063, and its 52-week low/high is $0.0075/$0.415.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Invests in WeedCoin Cryptocurrency -- CFN Media

NetworkNewsWire Announces Publication Discussing Bitcoin's Potential to Fill the Void of Federal Banking Resources in the Legal Marijuana Industry

SinglePoint Inc. Announces Purchase of $Weed as Money from Joint Venture Partner First Bitcoin Capital

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.07, up 16.67%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 9,467 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

Algae Dynamics Corp Announces Engagement of Atlanta-Based Broker Dealer Carter, Terry & Company

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Penny Pick Finders
(WTCG) +64.47%

2.

CFN Media Group
(SING) +52.33%

3.

QualityStocks
(ZYXI) +35.80%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251